Taiho Pharmaceutical Co., Ltd.

This study tests a drug called TAS-205 in 104 people with Duchenne muscular dystrophy, a genetic disease that weakens muscles over time. The goal is to see if the drug can help them move more easily, like standing up from the floor or walking. Participants are split into two grou…

This early-phase study tests a new drug (TAS-116) combined with imatinib in people with advanced gastrointestinal stromal tumors (GIST) that no longer respond to imatinib alone. About 78 participants will receive different treatments to find the safest dose and see if the combo c…